Biotech China 2014
BIO-Europe 2008
m:con Congress Center Rosengarten
Rosengartenplatz 2
68161 Mannheim, Germany,

Schedule of Presentations:

Monday, November 17, 2008
09:00:00 Maximizing Your Deal: The Business Case for Translational Medicine in Oncology Linda Pullan, John Freshley, Aron Knickerbocker, GAnesh Iyer
10:45:00 Rethinking R&D: Can Big Pharma Address the Productivity Gap through Earlier-Stage Collaborations? Ted Torphy, Bernhard Kirschbaum, Michael A. Yeomans, Barbara Yanni, Vaughn M. Kailian
11:45:00 A Day in the Life of Experienced Dealmakers – Year 6! James Watson, Simon Moroney, Shaun Grady, Mark Mcdade, Andrew Gengos, Simon Turton, William R. Ringo
12:00:00 Biotech-CMO Partnerships – Ways to Create Value Klaus Binder
12:00:00 Re-invention of the Drug Industry – Case Studies and Their Implications for Future Dealmaking Edwin Moses, Julie Teigland,, Klaus Wilgenbus, Holger Reithinger, Karsten Henco
12:00:00 US Patent Law in Flux: Can Dealmakers Adjust? Stephen S Yoder, Sven Riethmueller, Rouget Henschel
12:00:00 Dealmaking in China simon bury, Jimmy Wei, Sofie Qiao, Ruediger Herrmann, Darren Ji
12:00:00 Critical Issues to Consider when Entering the U.S. Market and Partnering with U.S. Companies Chris Yochim, Steve Bryant, Ray Briscuso,, Joe Dillon, Jørn Roland Müller
13:30:00 Financing Companies / Building Companies – Two Sides of the Same Coin or Different Currencies? Allan Marchington, Hubert Birner, Siegfried Bialojan, Friedrich von Bohlen und Halbach
13:30:00 M&A – The (Hidden) Objective of Every Partnering Deal? Georg Buchner, Edward Saltzman, Olivier Litzka
13:30:00 Demonstrating the Value of New Drugs Wayne Critchley, Karen Bernstein, David Sykes
14:45:00 Pharma Presentations
14:45:00 Biomarkers – Leading the Way for Personalized Medicine and Drug Development Michael Pennington, Albine Martin, M Plutz
14:45:00 Boehringer Ingelheim (CD Biopharmaceuticals)
14:45:00 The Early Stage Company: Preparing for Success Peter Johann, Steve Damon, Diane Romza Kutz, Tim Edwards
14:55:00 Baxter
15:00:00 Boehringer Ingelheim (CD Licensing)
15:15:00 Bayer Schering
15:35:00 Wyeth
16:00:00 Early Stage Dealmaking – How to Build Value Instead of Giving it Away Sarah Holland, Guido Lanza,, Louis J Scotti, Neill MacKenzie
16:00:00 Dealmaking with Japanese Companies Martina Molsbergen, Jeffrey D. Wager, Richard Hammel
16:15:00 Novartis
16:35:00 Astra Zeneca
16:55:00 Merck Serono
17:15:00 Transformative Trends in Oncology Melinda Shockley, William Levine, Gardiner Smith
17:15:00 What Buyers Want: Understanding What Big Pharma Expect to See in Out-Licensing Documents Axel Maibuecher, Ben Bonifant, Gwen Melincoff, Lubor Gaal
17:15:00 Pfizer
17:35:00 BMS
17:55:00 Merck & Co.
Tuesday, November 18, 2008
11:45:00 A Day in the Life of Experienced Dealmakers – Year 6! William R. Ringo, Mark Mcdade, Andrew Gengos, Simon Turton, Simon Moroney, Shaun Grady, James D Watson
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.